REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

04/05/2020 11:45

RNS Number : 8130L
  
Morgan Stanley Capital Services LLC
  
04 May 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley Capital Services LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   01 MAY 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  33,974


 84.1100 USD


 80.8500 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  38,737


 83.9800 USD


 81.5600 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 732


 81.9249 USD




 CFD


 LONG


 1,191


 81.9249 USD




 CFD


 LONG


 1


 82.0000 USD




 CFD


 LONG


 46


 82.0000 USD




 CFD


 LONG


 10,115


 82.8400 USD




 CFD


 LONG


 6,495


 82.9221 USD




 CFD


 LONG


 570


 83.0748 USD




 CFD


 SHORT


 400


 82.1250 USD




 CFD


 SHORT


 4,980


 82.7993 USD




 CFD


 SHORT


 1,166


 82.7993 USD




 CFD


 SHORT


 100


 82.8000 USD




 CFD


 SHORT


 1,188


 82.8400 USD




 CFD


 SHORT


 100


 82.9600 USD




 CFD


 SHORT


 400


 82.9600 USD




 CFD


 SHORT


 300


 82.9600 USD




 CFD


 SHORT


 300


 82.9600 USD




 CFD


 SHORT


 13,615


 82.9887 USD




 CFD


 SHORT


 23


 83.5000 USD




 CFD


 SHORT


 10,156


 83.7628 USD



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 04 MAY 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEUSSKRRAUVRRR